Search Login Register

Buserelin (Suprefact) Summary

Description: A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.

Also Known As: Suprefact; Aventis Brand of Buserelin; Aventis Brand of Buserelin Acetate; Bigonist; Buserelin Acetate Show All >>

Networked: 452 relevant articles (60 outcomes, 94 trials/studies) for this Bio-Agent

Key Diseases for which Buserelin is Relevant

  1. Endometriosis (Adenomyosis) : 15 outcomes 20 studies in 93 results
  2. Prostatic Neoplasms (Prostate Cancer) : 10 outcomes 20 studies in 74 results
  3. Neoplasms (Cancer) : 7 outcomes 7 studies in 31 results
  4. Precocious Puberty : 6 outcomes 6 studies in 28 results
  5. Carcinoma (Carcinomatosis) : 6 outcomes 5 studies in 38 results
Show All >>

Drugs Related to Buserelin

  1. Gonadotropin-Releasing Hormone (GnRH)
  2. Tamoxifen
  3. Hormones
  4. Danazol (Azol)
  5. Gonadotropins
  6. DNA (Deoxyribonucleic Acid)
  7. Estradiol (Estrace)
  8. Leuprolide (Lupron)
  9. Testosterone (Sustanon)
  10. Triptorelin (Trelstar)
Show All >>

Therapies Related to Buserelin

  1. Orchiectomy (Orchidectomy)
  2. Castration
  3. Subcutaneous Injections
  4. Withholding Treatment
  5. Ovariectomy (Oophorectomy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.